Adverse events when using benzbromarone in 98 patients
| Adverse events using benzbromarone | Low excretors (n = 36) | Normal to high excretors (n = 27) | Unknown excretor type at baseline (n = 35) | Total (n = 98) |
|---|---|---|---|---|
| Medical decision to stop benzbromarone | 10 (28%) | 4 (15%) | 4 (11%) | 18 (18%) |
| Renal stones | 0 | 0 | 1 (3%) | 1 (1%) |
| Decreased renal function | 0 | 2 (7%) | 2 (6%) | 4 (4%) |
| Diarrhea | 4 (11%) | 3 (11%) | 2 (6%) | 9 (9%) |
| Patient decision to stop benzbromarone (subjective reasons) | 0 | 5 (18%) | 1 (3%) | 6 (6%) |
| Liver toxicity | 0 | 1 (4%) | 0 | 1 (1%) |
| Ongoing therapy | 13 (36%) | 7 (26%) | 18 (51%) | 38 (38%) |
The data in the table is presented in the form of “n (percentage)”